Kirk Emick, MPA, ATC, LAT in University, MS - Physical Medicine & Rehabilitation

Kirk Emick, MPA, ATC, LAT is a Physical Medicine & Rehabilitation - Sports Medicine physician based in University, Mississippi. Kirk Emick is licensed to practice in Mississippi (license number AT0443) and his current practice location is 1810 Manning Way, University, Mississippi. He can be reached at his office (for appointments etc.) via phone at (662) 915-1834.

NPI number for Kirk Emick is 1518271634 and his current mailing address is 1810 Manning Way, University, Mississippi. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1518271634.

Contact Information

	Kirk Emick, MPA, ATC, LAT
	1810 Manning Way, University, MS 38677-9985
	(662) 915-1834
	Not Available

Physician's Profile

Full Name	Kirk Emick
Gender	Male
Speciality	Physical Medicine & Rehabilitation - Sports Medicine
Location	1810 Manning Way, University, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1518271634
Provider Enumeration Date: 07/30/2010
Last Update Date: 07/30/2010

Medical Identifiers

Medical identifiers for Kirk Emick such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518271634	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2081S0010X	Physical Medicine & Rehabilitation - Sports Medicine	AT0443 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kirk Emick is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kirk Emick, MPA, ATC, LAT 1810 Manning Way, University, MS 38677-9985 Ph: () -	Kirk Emick, MPA, ATC, LAT 1810 Manning Way, University, MS 38677-9985 Ph: (662) 915-1834

News Archive

New path may lead to powerful adjunctive novel therapy for PTSD treatment

There are currently only two FDA-approved medications for the treatment of posttraumatic stress disorder (PTSD) in the United States. Both of these medications are serotonin uptake inhibitors. Despite the availability of these medications, many people diagnosed with PTSD remain symptomatic, highlighting the need for new medications for PTSD treatment.

Central sclera thickening characterises dome-shaped macula

A dome-shaped macula appears to result from the relative thickening of the central macular sclera, researchers have found.

Global phase III study to provide novel extended release of topiramate

Data presented yesterday showed that USL255, a novel extended-release (ER) formulation of topiramate, was associated with less fluctuation in topiramate plasma levels than immediate-release (IR) topiramate in healthy volunteers.

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.

Kirk Emick, MPA, ATC, LAT - Physical Medicine & Rehabilitation in University, MS